Suppliers / Pierre Fabre Medicament Production

Pierre Fabre Medicament Production

France 176 employees Updated 9 July 2026

Pierre Fabre Medicament Production is a finished-dose manufacturer based in France. It appears in 78 regulatory filings across 8 regulators, without an active US DMF or CEP on file. Its filings concentrate with DPM (TN), EDE (AE) and MINSA (CR). Its GMP standing is certified by ANSM (FR), EMA and NAFDAC (NG), among 5 authorities.

0
active US DMFs
0
valid CEPs
10
registered plants 1 with an FDA FEI number
78
filings across 8 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Cahors, United Arab Emirates Not on file
Gien Cedex, United Arab Emirates Not on file
Gien, United Arab Emirates Not on file
GIEN, France Not on file
France, France 3006185766
Cahors, France Not on file

4 further sites are on record.

Filings and GMP by regulator

Regulator Filings GMP certificates
DPM (TN) 34 None
EDE (AE) 12 None
MINSA (CR) 10 None
UZPHARM (UZ) 9 None
EEC_EAEU 5 None
DIGEMAPS (DO) 4 None
ANSM (FR) None 14
EMA None 4
NAFDAC (NG) None 1
ANVISA (Brazil) None 1
EAEU_EEC None 1

Scale

Year Revenue Exports Destinations
2024 $0 Not reported Not reported

Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.

Questions about Pierre Fabre Medicament Production

Does Pierre Fabre Medicament Production hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Pierre Fabre Medicament Production. It does have 78 filings with 8 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Pierre Fabre Medicament Production FDA-registered?
One site operated by Pierre Fabre Medicament Production carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
Where does Pierre Fabre Medicament Production manufacture?
10 registered sites are on record, in United Arab Emirates, France and Tunisia (Cahors, Gien Cedex and Gien among others). Every site is listed on this page with the register it came from.
Which regulators recognise Pierre Fabre Medicament Production's GMP?
Current GMP certificates are on record from ANSM (FR), EMA, NAFDAC (NG), ANVISA (Brazil) and EEC (Eurasian Economic Union). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Pierre Fabre Medicament Production comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

AdhexPharma also in France Advanced Accelerator Applications also in France Aspen Notre Dame De Bondeville also in France Astrazeneca Dunkerque Production also in France Astrea Fontaine also in France

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Company filings
Revenue as reported